SCHEMBL6124695

SCHEMBL6124695

CCC1(CN)CCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
CYP2C19 P33261 1/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
RORC P51449 3/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
ENPP2 Q13822 1/20 0.44
ATXN2 Q99700 1/20 0.44
ACACB O00763 1/20 0.44
KDM1A O60341 1/20 0.43
ALDH1A1 P00352 3/20 0.43
USP2 O75604 1/20 0.43
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6124701 0.93 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL6124700 0.93 MEN1 (0.54) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL19622344 0.87 MEN1 (0.59) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL19622333 0.84 MEN1 (0.55) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL6127870 0.84 MEN1 (0.56) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL6127863 0.82 NPC1 (0.51) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL3273418 0.81 MEN1 (0.52) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL19779322 0.81 MEN1 (0.52) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL15504877 0.80 MEN1 (0.57) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19
SCHEMBL34473717 0.80 KDM1A (0.55) SMN1; SMN2MEN1KMT2ANPSR1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8487099-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2013-07-16 US disclosed
US-20120107328-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107328-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 SMN1; SMN2 1223/4885MEN1 3513/4885KMT2A 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.